ENFUSION INC - CLASS A (ENFN) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:ENFN - US2928121043 - Common Stock
10.76 USD
-0.04 (-0.37%)
10.76 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 51% to ENFN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.15. This target is 3.59% above the current price.
ENFN was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about ENFN.
In the previous month the buy percentage consensus was at a similar level.
ENFN was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-13 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-12-23 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-12-18 | Stifel | Maintains | Buy -> Buy |
| 2024-03-13 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-02-28 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2024-01-30 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-12-20 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-11-07 | UBS | Initiate | Neutral |
| 2023-08-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-22 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-05-10 | Credit Suisse | Maintains | Neutral |
| 2023-04-03 | Piper Sandler | Initiate | Neutral |
| 2023-03-15 | JP Morgan | Initiate | Neutral |
| 2023-01-26 | Goldman Sachs | Maintains | Neutral |
| 2023-01-04 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-01-03 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-10-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-08-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-14 | Goldman Sachs | Maintains | Neutral |
| 2022-07-06 | Piper Sandler | Maintains | Overweight |
| 2022-05-13 | Credit Suisse | Maintains | Neutral |
| 2022-05-13 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-03 | Credit Suisse | Maintains | Neutral |
| 2021-12-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-16 | William Blair | Initiate | Outperform |
| 2021-11-15 | Stifel | Initiate | Buy |
| 2021-11-15 | Goldman Sachs | Initiate | Neutral |
| 2021-11-15 | Credit Suisse | Initiate | Neutral |
| 2021-11-15 | B of A Securities | Initiate | Buy |
ENFUSION INC - CLASS A / ENFN FAQ
What is the price target for ENFN stock?
11 analysts have analysed ENFN and the average price target is 11.15 USD. This implies a price increase of 3.59% is expected in the next year compared to the current price of 10.76.
What is the consensus rating for ENFN stock?
The consensus rating for ENFUSION INC - CLASS A (ENFN) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for ENFUSION INC - CLASS A stock?
The number of analysts covering ENFUSION INC - CLASS A (ENFN) is 11.